Key facts
- Plenful’s last known valuation is $68.0M (May 2024).
- It has raised $76.0M across 2 recorded rounds; the latest was Early Stage VC (Series B) ($50.0M) in May 2025.
- Notable investors include Bessemer Venture Partners, Kevin Moore, Susa Ventures, Notable Capital, TQ Ventures — 12 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Plenful
Funding rounds
2 roundsAbout Plenful
Developer of AI-powered healthcare automation software designed to automate repetitive and manual workflows. The company's platform increases efficiency and data accuracy around manual and administrative healthcare operational workflows, enabling healthcare providers to save healthcare workers time, reduce costs, and drive revenue growth.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2021
- Employees
- 73
- Website
- plenful.com/
- Ownership
- Privately Held (backing)
Plenful doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Plenful shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Plenful in its N-PORT filings yet. We sweep new filings monthly.